Philanthropy

Donor-Advised Impact Philanthropy

Cures Within Reach works with each prospective, new and renewing funding partner to develop a customized program to match their own goals. Our funding partners represent individual donors, family offices, family foundations, private foundations, corporate foundations / social responsibility departments as well as others – all interested in finding and funding clinical research to help scientists and clinicians find new uses for existing drugs, medical devices and other treatments. Our funding helps to provide the initial proof-of-concept or pilot data needed to bring these treatments to patients with unmet or unsolved medical needs.

Impact philanthropy with faster patient impact, customized to a funder’s goals

Donors have flexibility and control over involvement during the search, selection and approval processes
CWR provides access to our entire 50+ research partner network; a due diligence process using external grant reviewers representing research, industry, clinicians and the patient voice to support project selection; expertise in finding, selecting, de-risking and managing repurposing-specific clinical research projects; and both project and financial progress reports during and after the project
CWR funding of clinical repurposing projects often catalyzes follow‐on funding from NIH, foundations and investors



Donor-advised funding can support a specific disease, patient population or geographic region

Research grants starting at US$50,000 can support a small, proof‐of‐concept human clinical trial or speed patient impact for a larger clinical trial

Example Areas of Focus

Pediatric diseases
Impacting veterans’ issues
Impacting health disparities
Led by a minority, underserved or female researcher in any disease area
In rare diseases, oncology, neurology (both mental health and neurodegenerative)
Chicago-based research (or another geographic area of interest)

Recent Examples of Donor-Advised Impact Philanthropy

A family foundation funded our first clinical repurposing trial in health disparities, to reduce the impact of COVID19 focused on Black and Latinx communities in Chicago
A major pharma company supported minority or underserved researchers with projects in low or low-middle income countries
Funds pooled from two pharma companies supported CureAccelerator Live! for Rare Diseases, selecting the winning rare disease project
An anonymous family funded two clinical repurposing trials in Huntington’s disease
A private foundation supported Impact Awards for Chicago repurposing startups